BackVaxcyte Overview

Vaxcyte Net Tangible Assets

Vaxcyte's net tangible assets is $2.8B.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$2.76B
↓ 10.20% YoYΔ $-313.39M vs prior year quarter

Peer trimmed avg / median

Loading

Vaxcyte Net Tangible Assets History

Loading

Vaxcyte vs. peers: Net Tangible Assets Comparison

Loading

Vaxcyte Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Vaxcyte (PCVX) FAQ

As of the most recent data (June 2026), PCVX shows a net tangible assets of $2.8B. That compares with $3.1B in the prior-year period — down 10.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PCVX's net tangible assets is now $2.8B (was $3.1B) — a 10.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Vaxcyte is outperforming or lagging.

Tracking PCVX's net tangible assets over time shows whether Vaxcyte is scaling, shrinking, or reshaping that part of the business. The current reading is $2.8B That compares with $3.1B in the prior-year period — down 10.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Vaxcyte's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $2.8B) with ownership activity and broader fundamentals.

Vaxcyte's net tangible assets is $2.8B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.